Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Preconference

Cell & Gene Therapies

Quantitative Pharmacology Approach to Inform the Bench-to-Bed Translation of CRSPR-Based in-vivo Gene Editing Therapy across Multiple Development Phases

Sunday, November 10, 2024
9:50 AM – 10:15 AM MST
Location: Sonoran Sky Ballroom 4

    Speaker(s)

  • Ahmed Abdelhady Abozeid, PhD (he/him/his)

    Clinical Pharmacology Director
    Intellia

    Disclosure(s): Intellia Therapeutics: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Disclosure(s):
Ahmed Abdelhady Abozeid, PhD: Intellia Therapeutics: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Back to Top